G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma
Clinical trial NCT07184788 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07184788
- Sponsor
- Navy General Hospital, Beijing
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2030-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.